2026 Annual Meeting | C137 - Cognitive, Behavioral, and Disease-modifying Therapeutics in Dementia

Date Tuesday 04/21/26

Time 01:00 PM - 03:00 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Lealani M. Acosta, MD, MPH, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should become familiar with the indication for and clinical utility of pharmacological and non-pharmacological therapeutics for dementia related cognitive and behavioral symptoms, and learn about the proper utilization of disease modifying treatments for dementia and their role in clinical practice.
Participants will apply principles of behavioral tools and indications for pharmacological management and disease modifying treatment for dementia by selecting appropriate therapies.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
01:00 PM - 01:05 PM CDT	Introduction	Introduction Lealani M. Acosta, MD, MPH, FAAN
01:05 PM - 01:40 PM CDT	Speaker	Non-Pharmacological Management of Dementia Julio C. Rojas-Martinez, MD, PhD
01:40 PM - 02:15 PM CDT	Speaker	Pharmacological Management of Dementia Lealani M. Acosta, MD, MPH, FAAN
02:15 PM - 02:20 PM CDT	Q&A	Q&A For Non-Pharmacological and Pharmacological Management of Dementia Lealani M. Acosta, MD, MPH, FAAN, Meredith Wicklund, MD, FAAN, Julio C. Rojas-Martinez, MD, PhD
02:20 PM - 02:55 PM CDT	Speaker	Disease-Modifying Therapeutics in Dementia Meredith Wicklund, MD, FAAN
02:55 PM - 03:00 PM CDT	Q&A	Q&A For Disease-Modifying Therapeutics in Dementia Meredith Wicklund, MD, FAAN

Faculty Disclosures
Lealani M. Acosta, MD, MPH, FAAN	Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Sage, NIH, Bristol Myers Squibb/Fortrea, CND Life Sciences.
Meredith Wicklund, MD, FAAN	The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Julio C. Rojas-Martinez, MD, PhD	Dr. Rojas-Martinez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ferrer International, S.A.. The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. The institution of Dr. Rojas-Martinez has received research support from Amylyx.

��ɫ��

��ɫ��